We are live on ! Find out more
STXS icon

Stereotaxis
STXS

74 hedge funds and large institutions have $180M invested in Stereotaxis in 2020 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

288% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 8

87% more capital invested

Capital invested by funds: $96.3M → $180M (+$83.7M)

62% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 13

45% more funds holding

Funds holding: 51 → 74 (+23)

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

9.35% more ownership

Funds ownership: 46.16% → 55.52% (+9.4%)

Holders
74
Holders Change
+23
Holders Change %
+45.1%
% of All Funds
1.52%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.08%
New
31
Increased
21
Reduced
13
Closed
8
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$2K

Top Buyers

1
CCM
Consonance Capital Management
New York
+$14.8M
2
BlackRock
BlackRock
New York
+$10.5M
3
State Street
State Street
Massachusetts
+$2.39M
4
Northern Trust
Northern Trust
Illinois
+$1.82M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.12M

Top Sellers

1
OM
Opaleye Management
Massachusetts
-$1.42M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.05M
3
APCM
Arbiter Partners Capital Management
New York
-$938K
4
ECM
ExodusPoint Capital Management
New York
-$718K
5
PVI
Pura Vida Investments
New York
-$514K
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
1
DAFNA Capital Management
California
$61M – – –
APCM
2
Arbiter Partners Capital Management
New York
$19.8M -$938K -231,810 -5%
CCM
3
Consonance Capital Management
New York
$16.3M +$14.8M +3,658,537 New
OM
4
Opaleye Management
Massachusetts
$15.7M -$1.42M -350,000 -9%
RG
5
Redmile Group
California
$13.8M – – –
BlackRock
6
BlackRock
New York
$11.9M +$10.5M +2,594,803 +3,438%
Vanguard Group
7
Vanguard Group
Pennsylvania
$8.07M +$815K +201,315 +13%
PVI
8
Pura Vida Investments
New York
$4.02M -$514K -127,006 -12%
Millennium Management
9
Millennium Management
New York
$3.09M +$826K +204,099 +42%
PHP
10
Parkman Healthcare Partners
Connecticut
$2.98M +$60.7K +15,000 +2%
State Street
11
State Street
Massachusetts
$2.64M +$2.39M +591,037 New
Northern Trust
12
Northern Trust
Illinois
$2.32M +$1.82M +450,635 +642%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$2.32M +$1.12M +276,064 +113%
UBS Group
14
UBS Group
Switzerland
$1.39M +$783K +193,522 +165%
RC
15
Roubaix Capital
Colorado
$1.12M +$1.01M +250,613 New
AA
16
AlphaCentric Advisors
Puerto Rico
$1.11M +$1.01M +250,000 New
EIM
17
Essex Investment Management
Massachusetts
$1.08M -$4.87K -1,203 -0.5%
Goldman Sachs
18
Goldman Sachs
New York
$978K +$248K +61,293 +39%
SV
19
Sturgeon Ventures
United Kingdom
$910K +$521K +128,774 +171%
N
20
Nuveen
North Carolina
$656K +$595K +147,034 New
GC
21
GMT Capital
Georgia
$565K +$415K +102,457 +425%
EI
22
EAM Investors
California
$560K -$310K -76,543 -38%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$519K +$401K +98,983 +574%
MCM
24
Marathon Capital Management
Maryland
$503K +$13.2K +3,250 +3%
Charles Schwab
25
Charles Schwab
California
$497K +$385K +95,206 +588%
1
2 3 4

STXS Hedge Fund Activity: Q2 2020 in Review

74 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Stereotaxis (STXS) for Q2 2020, worth a combined $180M — up 87% from $96.3M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new STXS positions and 8 closed out — a net gain of 23 holders — while 21 added to existing stakes and 13 trimmed.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $14.8M. The largest seller was Opaleye Management, cutting an estimated $1.42M.

  • 74 institutional investors held Stereotaxis (STXS) as of Q2 2020, up from 51 in Q1 2020.
  • Funds reported $180M of Stereotaxis stock for Q2 2020, up 87% quarter-over-quarter.
  • 31 funds opened new Stereotaxis positions in Q2 2020 and 8 closed out, a net change of +23 holders.
  • The largest Stereotaxis buyer in Q2 2020 was Consonance Capital Management, an estimated $14.8M added.
  • The largest Stereotaxis seller in Q2 2020 was Opaleye Management, an estimated $1.42M sold.

Based on aggregated 13F filings for Q2 2020.